PortfoliosLab logoPortfoliosLab logo
VRNA vs. SFM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VRNA vs. SFM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and Sprouts Farmers Market, Inc. (SFM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


VRNA

1D
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
ALL TIME*

SFM

1D
1.91%
1M
-12.29%
6M
4.83%
YTD
-6.00%
1Y
-54.45%
3Y*
24.08%
5Y*
24.80%
10Y*
11.97%
ALL TIME*
6.04%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$151.42M$179.07M$185.67M

VRNA vs. SFM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VRNA
Verona Pharma plc
0.00%130.21%133.60%-23.92%288.84%-4.00%21.74%-40.41%-18.71%-12.07%
SFM
Sprouts Farmers Market, Inc.
-6.00%-37.30%164.12%48.63%9.06%47.66%3.88%-17.69%-3.45%7.74%

Correlation

The correlation between VRNA and SFM is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Apr 27, 2017

0.05

The correlation between VRNA and SFM shifts across timeframes, from -0.04 (1 year) to 0.12 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VRNA:

$9.72B

SFM:

$7.04B

EPS

VRNA:

-$0.69

SFM:

$5.22

PS Ratio

VRNA:

57.97

SFM:

0.82

PB Ratio

VRNA:

34.92

SFM:

4.99

Total Revenue (TTM)

VRNA:

$167.65M

SFM:

$8.90B

Gross Profit (TTM)

VRNA:

$159.52M

SFM:

$3.41B

EBITDA (TTM)

VRNA:

-$40.86M

SFM:

$837.54M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VRNA vs. SFM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


SFM
SFM Risk / Return Rank: 88
Overall Rank
SFM Sharpe Ratio Rank: 33
Sharpe Ratio Rank
SFM Sortino Ratio Rank: 55
Sortino Ratio Rank
SFM Omega Ratio Rank: 44
Omega Ratio Rank
SFM Calmar Ratio Rank: 88
Calmar Ratio Rank
SFM Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. SFM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and Sprouts Farmers Market, Inc. (SFM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VRNASFMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.76

Calmar ratioReturn relative to maximum drawdown

-0.92

Martin ratioReturn relative to average drawdown

-1.20

VRNA vs. SFM - Sharpe Ratio Comparison


Loading charts...

Drawdowns

VRNA vs. SFM - Drawdown Comparison


Loading charts...

Drawdown Indicators


VRNASFMDifference

Max Drawdown

Largest peak-to-trough decline

-72.88%

Max Drawdown (1Y)

Largest decline over 1 year

-59.30%

Max Drawdown (3Y)

Largest decline over 3 years

-63.48%

Max Drawdown (5Y)

Largest decline over 5 years

-63.48%

Max Drawdown (10Y)

Largest decline over 10 years

-63.48%

Current Drawdown

Current decline from peak

-58.29%

Average Drawdown

Average peak-to-trough decline

-40.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.29%

Volatility

VRNA vs. SFM - Volatility Comparison


Loading charts...

Volatility by Period


VRNASFMDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.12%

Volatility (6M)

Calculated over the trailing 6-month period

30.93%

Volatility (1Y)

Calculated over the trailing 1-year period

47.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.02%

Dividends

VRNA vs. SFM - Dividend Comparison

Neither VRNA nor SFM has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VRNA vs. SFM - Financials Comparison

This section allows you to compare key financial metrics between Verona Pharma plc and Sprouts Farmers Market, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
75.14M
2.33B
(VRNA) Total Revenue
(SFM) Total Revenue
Values in USD except per share items

VRNA vs. SFM - Profitability Comparison

The chart below illustrates the profitability comparison between Verona Pharma plc and Sprouts Farmers Market, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
95.4%
39.4%
Portfolio components
VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

SFM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Sprouts Farmers Market, Inc. reported a gross profit of 917.28M and revenue of 2.33B. Therefore, the gross margin over that period was 39.4%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

SFM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Sprouts Farmers Market, Inc. reported an operating income of 215.31M and revenue of 2.33B, resulting in an operating margin of 9.2%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

SFM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Sprouts Farmers Market, Inc. reported a net income of 163.72M and revenue of 2.33B, resulting in a net margin of 7.0%.


Frequently Asked Questions


VRNA and SFM have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for VRNA and SFM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer